Neo Cremar Co., Ltd.
Financials
Valuation Metrics
Neo Cremar Co., Ltd.'s Market Cap is ₩295B. At end of 2025 it was ₩743B. Ranked #2053 of 2,436 in KR market (top 84%), #1302 of 1,649 on KOSDAQ (top 79%), #71 of 84 in Food, Beverage & Tobacco (top 85%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 29.48B KRW | KR#2,053/2,436 Sec#71/84 |
| Revenue | 80.23B KRW | KR#1,534/2,436 Sec#72/84 |
| Net Income | 4.17B KRW | KR#1,187/2,436 Sec#51/84 |
| Total Assets | 184.59B KRW | KR#1,335/2,436 Sec#60/84 |
| Net Assets | 145.81B KRW | KR#1,120/2,436 Sec#50/84 |
| Employees | 69 | KR#1,867/2,436 Sec#71/84 |
| Value | ||
| P/E | 7.07x | KR#496/2,436 Sec#25/84 |
| P/B | 0.20x | KR#123/2,436 Sec#7/84 |
| P/S | 0.37x | KR#732/2,436 Sec#57/84 |
| EV/EBITDA | 4.35x | KR#184/2,436 Sec#7/84 |
| FCF Yield | 50.76% | KR#87/2,436 Sec#10/84 |
| Profitability | ||
| ROE | 2.86% | KR#1,244/2,436 Sec#48/84 |
| ROA | 2.26% | KR#1,086/2,436 Sec#39/84 |
| Op. Margin | 4.13% | KR#1,035/2,436 Sec#43/84 |
| Revenue Growth | -8.24% | KR#1,817/2,436 Sec#75/84 |
| Earnings Growth | -34.76% | KR#1,135/2,436 Sec#51/84 |
| Financial Health | ||
| Debt Ratio | 126.60% | KR#791/2,436 Sec#25/84 |
| Total Debt | 13.02B KRW | KR#1,525/2,436 Sec#69/84 |
| FCF | 14.97B KRW | KR#598/2,436 Sec#40/84 |
| Cash | 28.11B KRW | KR#1,043/2,436 Sec#48/84 |
| Current Ratio | 3.82x | KR#448/2,436 Sec#3/84 |
| Net Debt/EBITDA | -4.56x | KR#144/2,436 Sec#2/84 |
| Dividend | ||
| Div. Yield | 2.17% | KR#862/2,436 Sec#48/84 |
| Performance | ||
| 1Y Return | -63.71% | KR#2,241/2,436 Sec#81/84 |
| 1M Return | -10.90% | KR#1,266/2,436 Sec#77/84 |
| From 52W High | -79.05% | KR#2,318/2,436 Sec#84/84 |
| 1Y MDD | -79.86% | KR#2,294/2,436 Sec#84/84 |
| Trading | ||
| Volume | 29,889 shares | KR#1,943/2,436 Sec#51/84 |
| Foreign Own. | 3.90% | KR—/2,436 Sec—/84 |
| Per Share | ||
| EPS | 153 KRW | KR#1,283/2,436 Sec#51/84 |
| BPS | 5,802 KRW | KR#1,332/2,436 Sec#56/84 |
Company Info
Established in 2007 with functional sugar and peptide product manufacturing and product distribution as its main businesses, the company was listed on KOSDAQ in 2019. Through its main subsidiary, BBC Co., Ltd., it operates material businesses such as monofilament and functional air filters, and healthcare businesses including toothbrushes. As a microbiome-based functional food material company, it produces galactooligosaccharides and low molecular weight yeast peptides, leading the market by globally launching organic galactooligosaccharides for the first time. Neocrema was established in 2007 and is headquartered in Gangnam-gu, Seoul.